Patent · US Active

Raman spectroscopy for non-invasive glucose measurements

US8355767B2 · kind B2 · utility

17Cited by
33References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2006
Grant dateJan 15, 2013
Priority date
Expiry dateMar 13, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N21/65
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to the use of Raman spectroscopy for quantitative, non-invasive transcutaneous measurement of blood analytes, such as glucose. Raman spectroscopy is used to measure glucose transcutaneously, in patients whose blood glucose levels were monitored. Raman spectra were collected transcutaneously along with glucose reference values provided by standard capillary blood analysis. A partial least squares calibration was created from the data from each subject and validated using leave-one-out cross validation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.